Scutellarin protects cortical neurons against neonatal hypoxic‐ischemic encephalopathy injury via upregulation of vascular endothelial growth factor
Abstract Neonatal hypoxic‐ischemic encephalopathy (NHIE) causes devastating cerebral damage and neurological deficits that seldom have effective therapies. This study aimed to explore the mechanisms underlying the therapeutic efficacy of Scutellarin in NHIE. NHIE models were successfully established...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2022-09-01
|
Series: | Ibrain |
Subjects: | |
Online Access: | https://doi.org/10.1002/ibra.12052 |